One of the investments I wish I held was NAN. Bought it around 17c at I think $70M mcap. Defensible technology in a niche market. Now's $2Bn and $6.74. Would have been a mortgage clearer. I agree with Doug. If CDX hit $500M, $2bn is just a stop on the way to $10bn or more - if all those products translate into revenue. Looking at NAN and Resmed's paths to multi billions, it's not just the revenue but also the booked assets increasing year on year: for me this means CDX is at least a 5-10 year play to anything in billions, but it has the business, products and management to get there.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.94M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49999 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| CDX (ASX) Chart |
Day chart unavailable